Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Study meets generally accepted scientific principles, minor restriction: only data for female rats; sufficient documentation of test conditions, less detailed documentation of test results; publication acceptable as a key study for acute toxicity

Data source

Reference
Reference Type:
publication
Title:
Acetone potentiation of acute acetonitrile toxicity
Author:
Freeman JJ, Hayes EP
Year:
1985
Bibliographic source:
J Toxicol Environ Health 15: 609-621

Materials and methods

Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
Undiluted acetone applied to female rats by gavage, dose range 5370 - 6980 mg/kg bw, post-observation 14 days for mortality, clinical signs, body weights, necropsy performed
GLP compliance:
no
Test type:
standard acute method

Test material

Constituent 1
Chemical structure
Reference substance name:
Acetone
EC Number:
200-662-2
EC Name:
Acetone
Cas Number:
67-64-1
Molecular formula:
C3H6O
IUPAC Name:
propan-2-one
Details on test material:
- Purity: at least 99%

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River Breeding Laboratories, Wilmington, Mass., USA
- Age at study initiation: not specified
- Weight at study initiation: 174-260 g
- Fasting period before study: overnight fast
- Housing: single
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: at least 7 d

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
unchanged (no vehicle)
Doses:
5370 to 6980 mg/kg
No. of animals per sex per dose:
5
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: signs of toxicity observed frequently on day of dosing, daily thereafter for 14 days; body weights prior to dosing, at 24, 48, 72 hrs and 7 and 14 days after dosing
- Necropsy performed on rats dying and on survivors: yes
- Other examinations performed: clinical signs, body weight, necropsy (not further specified)
Statistics:
LGD50 values according to method of Litchfield and Wilcoxon (1948)

Results and discussion

Effect levels
Sex:
female
Dose descriptor:
LD50
Effect level:
5 800 mg/kg bw
Mortality:
death within 48 to 72 hrs
Clinical signs:
other: initial signs: decreased activity and ataxia appeared within 3 hrs; animals appeared recovered after 24 hrs at 32-36 hrs: severe toxicity including tremors, tonus, convulsions signs preceeding death: were a state of prostration, usually without convulsion
Gross pathology:
no remarkable differences between dosage groups (no further details)

Applicant's summary and conclusion

Interpretation of results:
not classified
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
Acetone was practically nontoxic based on an oral LD50 value of 5800 mg/kg bw in female rats.
Executive summary:

Female Sprague-Dawley rats (N=5/group) were orally exposed to doses of 5370 to 6980 mg/kg for determination of LD50. Acetone was practically nontoxic based on an oral LD50 value of 5800 mg/kg bw in rats. Initial signs of intoxication, such as decreased activity and ataxia, appeared within 3 hrs of dosing. Rats appeared to be recovered after 24 hrs. At 32 to 36 hrs severe toxicity was indicated by tremors, tonus, and convulsions, and gradually progressed to death within 48 to 72 hrs. Clinical signs preceeding death were a state of prostration, usually without convulsions. Loss of weight up to 15% occured until 48 hrs after dosing, but started to be reversible at 72 hrs.